Statement from specialists in nicotine science and public health policy

List of signatories and transparency disclosures  

This is a list of the signatories to the letter sent to Dr Margaret Chan, Director general of WHO regarding tobacco harm reduction.

The signatories and full affiliations are set out below, followed by a table of transparency declarations.

Signatories: full titles and affiliation

Professor David Abrams

Professor of Health Behavior and Society.

The Johns Hopkins Bloomberg School of Public Health. Maryland. USA.  

Professor of Oncology (adjunct). Georgetown University Medical Center,

Lombardi Comprehensive Cancer Center. Washington DC.

United States of America

 

Professor Tony Axéll

Emeritus Professor Geriatric Dentistry

Consultant in Oral Medicine

Sweden

 

Professor Pierre Bartsch

Respiratory physician,

Faculty of Medicine

University of Liège

Belgium

 

Professor Linda Bauld

Professor of Health Policy

Director of the Institute for Social Marketing

Deputy Director, UK Centre for Tobacco and Alcohol Studies

University of Stirling

United Kingdom

 

Professor Ron Borland

Nigel Gray Distinguished Fellow in Cancer Prevention at Cancer Council Victoria

Professorial Fellow School of Population Health and Department of Information Systems

University of Melbourne,

Australia

 

Professor John Britton

Professor of Epidemiology;

Director, UK Centre for Tobacco & Alcohol Studies,

Faculty of Medicine & Health Sciences

University of Nottingham,

United Kingdom

 

Associate Professor Chris Bullen

Director, National Institute for Health Innovation

School of Population Health,

University of Auckland,

New Zealand

 

Professor Emeritus André Castonguay

Faculty of Pharmacy

Université Laval,

Quebec,

Canada.

 

Dr Lynne Dawkins

Senior Lecturer in Psychology,

Co-ordinator: Drugs and Addictive Behaviours Research Group

School of Psychology,

University of East London,

United Kingdom

 

Professor Ernest Drucker

Professor Emeritus

Department of Family and Social Medicine,

Montefiore Medical Center/Albert Einstein College of Medicine

Mailman School of Public Health

Columbia University

United States of America

 

Professor Jean François Etter

Associate Professor

Institut de santé globale,

Faculté de médecine,

Université de Genève,

Switzerland

 

Dr Karl Fagerström

President, Fagerström Consulting AB,

Vaxholm,

Sweden

 

Dr Konstantinos Farsalinos

Researcher, Onassis Cardiac Surgery Center, Athens, Greece

Researcher, University Hospital Gathuisberg, Leuven,

Belgium

Professor Antoine Flahault

Directeur de l'Institut de Santé Globale

Faculté de Médecine, Université de Genève, Suisse/ Institute of Global Health, University of Geneva, Switzerland

Professor of Public Health at the Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité,

France

 

Dr Coral Gartner

Senior Research Fellow

University of Queensland Centre for Clinical Research

The University of Queensland,

Australia

Dr Guillermo González

Psychiatrist

Comisión de Rehabilitación en Enfermedad Mental Grave

Clínica San Miguel

Madrid,

Spain

Dr Nigel Gray

Member of Special Advisory Committee on Tobacco Regulation of the World Health Organization

Honorary Senior Associate

Cancer Council Victoria,

Australia

 

Professor Peter Hajek

Professor of Clinical Psychology and Director, Health and Lifestyle Research Unit

UK Centre for Tobacco and Alcohol Studies

Wolfson Institute of Preventive Medicine,

Barts and The London School of Medicine and Dentistry Queen Mary University of London,

United Kingdom

 

Professor Wayne Hall

Director and Inaugural Chair, Centre for Youth Substance Abuse Research

University of Queensland

Australia

 

Professor John Hughes

Professor of Psychology, Psychiatry and Family Practice

University of Vermont

United States of America

 

Professor Martin Jarvis

Emeritus Professor of Health Psychology

Department of Epidemiology & Public Health

University College London,

United Kingdom

 

Professor Didier Jayle

Professeur d’addictologie

Conservatoire National des Arts et Métiers

Paris,

France

 

Dr Martin Juneau

Directeur, Direction de la Prévention

Institut de Cardiologie de Montréal

Professeur Titulaire de Clinique

Faculté de Médecine,

Université de Montréal,

Canada

 

Dr Michel Kazatchkine

Member of the Global Commission on Drug Policy

Senior fellow, Global Health Program, Graduate institute, Geneva,

Switzerland

 

Professor Demetrios Kouretas

School of Health Sciences and Vice Rector

University of Thessaly,

Greece

 

Professor Lynn Kozlowski

Dean, School of Public Health and Health Professions,

Professor of Community Health and Health Behavior,

University at Buffalo,

State University of New York,

United States of America

 

Professor Eva Králíková

Institute of Hygiene and Epidemiology

Centre for Tobacco-Dependence

First Faculty of Medicine

Charles University in Prague and General University Hospital in Prague,

Czech Republic

 

Professor Michael Kunze

Head of the Institute for Social Medicine

Medical University of Vienna,

Austria

 

Dr Murray Laugesen

Director

Health New Zealand, Lyttelton,

Christchurch,

New Zealand

 

Dr Jacques Le Houezec

Consultant in Public Health, Tobacco dependence, Rennes,

France

Honorary Lecturer, UK Centre for Tobacco Control Studies,

University of Nottingham,

United Kingdom

Dr Kgosi Letlape

President of the Africa Medical Association

Former President of the World Medical Association

Former Chairman of Council of the South African Medical Association

South Africa

 

Dr Karl Erik Lund

Research director

Norwegian Institute for Alcohol and Drug Research,

Oslo,

Norway

 

Dr Gérard Mathern

Président de l'Institut Rhône-Alpes de Tabacologie

Saint-Chamond,

France

Professor Richard Mattick

NHMRC Principal Research Fellow

Immediate Past Director NDARC (2001-2009)

National Drug and Alcohol Research Centre (NDARC)

Faculty of Medicine

The University of New South Wales,

Australia

 

Professor Ann McNeill

Professor of Tobacco Addiction

Deputy Director, UK Centre for Tobacco and Alcohol Studies

National Addiction Centre

Institute of Psychiatry

King's College London,

United Kingdom

 

Dr Hayden McRobbie

Reader in Public Health Interventions,

Wolfson Institute of Preventive Medicine,

Queen Mary University of London,

United Kingdom

Dr Anders Milton

Former President of the Swedish Red Cross

Former President and Secretary of the Swedish Medical Association

Former Chairman of the World Medical Association

Owner & Principal Milton Consulting,

Sweden

 

Professor Marcus Munafò

Professor of Biological Psychology

MRC Integrative Epidemiology Unit at the University of Bristol

UK Centre for Tobacco and Alcohol Studies

School of Experimental Psychology

University of Bristol,

United Kingdom

 

Professor David Nutt

Chair of the Independent Scientific Committee on Drugs (UK)

Edmund J Safra Professor of Neuropsychopharmacology

Head of the Department of Neuropsychopharmacology and Molecular Imaging

Imperial College London,

United Kingdom

 

Dr Gaston Ostiguy

Professeur agrégé

Directeur de la Clinique de cessation tabagique

Centre universitaire de santé McGill (CUSM)

Institut thoracique de Montréal,

Canada

 

Professor Riccardo Polosa

Full Professor of Internal Medicine

Director of the Institute for Internal Medicine and Clinical Immunology,

University of Catania, Italy.

 

Dr Lars Ramström

Director

Institute for Tobacco Studies

Täby,

Sweden

 

Dr Martin Raw

Special Lecturer

UK Centre for Tobacco and Alcohol Studies

Division of Epidemiology and Public Health

University of Nottingham,

United Kingdom

Professor Andrzej Sobczak

Department of General and Inorganic Chemistry,

Faculty of Pharmacy and Laboratory Medicine,

Medical University of Silesia, Katowice, Poland

Institute of Occupational Medicine and Environmental Health

Sosnowiec,

Poland

 

Professor Gerry Stimson

Emeritus Professor, Imperial College London;

Visiting Professor, London School of Hygiene and Tropical Medicine

United Kingdom

Professor Tim Stockwell

Director, Centre for Addictions Research of BC

Professor, Department of Psychology

University of Victoria, British Columbia,

Canada

 

Professor David Sweanor

Adjunct Professor, Faculty of Law, University of Ottawa

Special Lecturer, Division of Epidemiology and Public Health,

University of Nottingham,

United Kingdom

 

Professor Umberto Tirelli

Director Department of Medical Oncology

National Cancer Institute of Aviano

Italy

 

Professor Umberto Veronesi

Scientific Director

IEO Istituto Europeo di Oncologia

Former Minister of Health,

Italy

 

Professor Kenneth Warner

Avedis Donabedian Distinguished University Professor of Public Health

Professor, Health Management & Policy

School of Public Health

University of Michigan

United States of America

 

Professor Robert West

Professor of Health Psychology and Director of Tobacco Studies

Health Behaviour Research Centre,

Department of Epidemiology & Public Health,

University College London

United Kingdom

 

Professor Dan Xiao

Director of Department Epidemiology

WHO Collaborating Center for Tobacco or Health

Beijing Institute of Respiratory Medicine,

Beijing Chao-Yang Hospital, China

 

Dr Derek Yach

Former Executive Director, Non-Communicable Diseases

Former Head of Tobacco Free Initiative,

World Health Organisation (1995-2004)

Senior Vice President Vitality Group plc

Director, Vitality Institute for Health Promotion

United States of America

Transparency declarations of signatories

Disclosure statements have been made in order to apply the same standards of transparency required for publication in peer-reviewed academic journals.

 Signatories

Competing interest statement

Professor David Abrams

None

Professor  Tony Axéll

None

Professor Pierre Bartsch

None

Professor Linda Bauld

I chaired the National Institute for Health and Care Excellence Programme Development Group on tobacco harm reduction.

Professor Ron Borland

None

Professor John Britton

None

Associate Professor Chris Bullen

I was principal investigator on a public-good funded e-cigarette trial for which PGM International provided products at no cost, and have undertaken research on Ruyan e-cigarettes, for which my employer,  the University of Auckland, was funded by Health New Zealand, independently of Ruyan. I have received benefit in kind from a manufacturer of nicotine replacement therapy for a presentation. I have not received personal benefit or research funding from the manufacturers of e-cigarettes or tobacco.

Professor André Castonguay

None

Dr Lynne Dawkins

I have undertaken research for e-cigarette companies for which the University of East London received funding.  I have also received speaker honoraria and products from e-cigarette companies for research purposes. I have no COI with the tobacco or pharmaceutical industry.  

Professor Ernest Drucker

None

Professor Jean François Etter

My salary is paid by the University of Geneva. I was reimbursed by a manufacturer of e-cigarettes and e-liquids for traveling to London and to China, to visit e-cigarette factories, but I did not receive any honoraria for these meetings.

Dr Karl Fagerström

I have been a consultant to most companies marketing smoking cessation products products including Niconovum and Nicoventures. Member of an oversight Advisory Panel (unpaid) for a low  nitrosamine smokeless product (snus) with the intent to  obtain a Modified Tobacco Risk Product license from FDA.

Dr Konstantinos Farsalinos

 Some of my studies were performed by using funds provided to the institution by e-cigarette companies. All studies were investigator-initiated and investigator-driven.

Professor Antoine Flahault

One of my relatives work at LEEM (an organisation representing the pharmaceutical industries), and my research lab has received a grant from Sanofi.

Dr Coral Gartner

None

Dr Guillermo González

None

Dr Nigel Gray

None

Professor Peter Hajek

Received research funding from and provided consultancies to manufacturers of stop-smoking medications.

Professor Wayne Hall

 None

Professor John Hughes

 I have received consulting fees and presentation honorariums from many for-profit and non-profit organizations that develop or market smoking cessation medications, devices and treatments and from non-profit organizations that engage in tobacco control

Professor Martin Jarvis

I am a trustee of ASH; a member of the  MHRA Working Group on nicotine-containing products; I was a member of the UK National Institute for Health and Care Excellence guidelines group on tobacco harm reduction;  I have consulted for for companies that develop and manufacture smoking cessation medicines. I have no COI with tobacco or e-cigarette  companies.

Professor Didier Jayle

 None

Professor Martin Juneau

 None

Dr Michel Kazatchkine

 None

Professor Demetrios Kouretas

The University of Thessaly signed a research proposal between University and the Greek Chamber of e-cigarettes importers to test the toxicity of the liquids that are sold in the Greek market. I have not received money from any e-cigarette company.

Professor Lynn Kozlowski

 None

Dr Eva Králíková

I have been involved in clinical studies and educational activities for pharmaceutical companies producing tobacco dependence treatments

Professor Michael Kunze

None

Dr Murray Laugesen

None

Dr Jacques Le Houezec

I received speaker honoraria and consultancy fees from Johnson & Johnson, Novartis, Pfizer, and Pierre Fabre. I have no COI with tobacco or e-cigarettes companies.

Dr Kgosi Letlape

None

Dr Karl Erik Lund

None

Dr Gérard Mathern

I received honoraria as speaker and teacher from, Pfizer, and Pierre Fabre. I have no COI with tobacco or e-cigarettes companies.

Professor Richard Mattick

None

Professor Ann McNeill

None

Dr Anders Milton

None

Dr Hayden McRobbie

I was an investigator in a public-good funded ASCEND e-cigarette trial for which PGM International provided products at no cost, and have undertaken research on Ruyan e-cigarettes, for which the University of Auckland was funded by Health New Zealand, independently of Ruyan. I have also provided consultancy for and received research funding from manufacturers of smoking cessation medications (Pfizer, Johnson & Johnson, and GlaxoSmithKline).

Professor Marcus Munafò

Received grant funding from Pfizer, and nicotine replacement products from GlaxoSmithKline and Pfizer for distribution to study participants.

Professor David Nutt

None

Dr Gaston Ostiguy

None

Professor Riccardo Polosa

Riccardo Polosa has received grant support from anti-asthma drug manufacturers including CV Therapeutics, NeuroSearch A/S, Sandoz, Merck Sharp & Dohme, and Boehringer-Ingelheim; has served as a consultant for CV Therapeutics, Duska Therapeutics, Neuro-Search A/S, Boehringer-Ingelheim, and Forest Laboratories; has also received  lecture fees and research funding from GlaxoSmithKline and Pfizer, manufacturers of stop smoking

medications; he has also served as a consultant for Pfizer and Arbi Group Srl, an italian e-cigs distributor. Riccardo Polosa’s research on e-cigs, smoking and asthma is supported by University of Catania and Lega Italiana AntiFumo (LIAF).

Dr Lars Ramström

 None

Dr Martin Raw

 None

Professor Andrzej Sobczak

I have undertaken research for Chic Group Ltd. manufacturer of electronic cigarettes in Poland for which the Institute of Occupational Medicine and Environmental Health received funding. I have also received expert report and speaker honoraria and products for research purposes from Chic Group Ltd. I have no COI with the tobacco or pharmaceutical industry.

Professor Gerry Stimson

Member of the UK National Institute for Health and Care Excellence guidelines group on tobacco harm reduction; director of K•A•C, which received a research feasibility grant from a company developing a nicotine delivery device.

Professor Tim Stockwell

None

Professor David Sweanor

None

Professor Umberto Tirelli

None

Professor Umberto Veronesi

 

Professor Kenneth Warner

 None

Professor Robert West

 I undertake research and consultancy for companies that develop and manufacture smoking cessation medicines but not e-cigarettes companies or any companies acting for them. My salary is supported by Cancer Research UK. I am a trustee of the charity, QUIT. I am honorary co-director of the UK’s National Centre for Smoking Cessation and Training.

Professor Dan Xaio

I have consulted for some companies who produce smoking cessation drugs, no other to declare

Dr Derek Yach

Led tobacco control at WHO; involved in research on e-cigs and have no financial ties to tobacco or e-cig companies.

Clive Bates (co-ordination)

 None